// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Ten guides will visit German museums to identify and learn the newest principles of museum management and presentation.
Dilijan joins a dynamic network of cities worldwide that support and accelerate the practice of lifelong learning in the world’s communities.
Leaving a note in the museum’s memory book, Hidalgo called on the world to acknowledge the truth and recognize the Genocide.
According to one of the organizers, visitors can take part in activities, attend master classes and spend the night at villagers’ homes.
Partner news